HK1201283A1 - 丙型流感病毒和疫苗 - Google Patents

丙型流感病毒和疫苗

Info

Publication number
HK1201283A1
HK1201283A1 HK15101817.2A HK15101817A HK1201283A1 HK 1201283 A1 HK1201283 A1 HK 1201283A1 HK 15101817 A HK15101817 A HK 15101817A HK 1201283 A1 HK1201283 A1 HK 1201283A1
Authority
HK
Hong Kong
Prior art keywords
influenza
vaccine
virus
Prior art date
Application number
HK15101817.2A
Other languages
English (en)
Inventor
Randy R Simonson
Emily A Collin
Benjamin M Hause
Original Assignee
Newport Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Newport Lab Inc filed Critical Newport Lab Inc
Publication of HK1201283A1 publication Critical patent/HK1201283A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16311—Influenzavirus C, i.e. influenza C virus
    • C12N2760/16321—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16311—Influenzavirus C, i.e. influenza C virus
    • C12N2760/16322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16311—Influenzavirus C, i.e. influenza C virus
    • C12N2760/16334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
HK15101817.2A 2012-01-27 2015-02-18 丙型流感病毒和疫苗 HK1201283A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13/385,004 US9278999B2 (en) 2012-01-27 2012-01-27 Influenza C virus and vaccine
PCT/US2013/023441 WO2013112995A1 (en) 2012-01-27 2013-01-28 Influenza c virus and vaccine

Publications (1)

Publication Number Publication Date
HK1201283A1 true HK1201283A1 (zh) 2015-08-28

Family

ID=47714564

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15101817.2A HK1201283A1 (zh) 2012-01-27 2015-02-18 丙型流感病毒和疫苗

Country Status (13)

Country Link
US (1) US9278999B2 (zh)
EP (1) EP2807184A1 (zh)
JP (1) JP6257529B2 (zh)
CN (1) CN104203972A (zh)
AU (1) AU2013211833B2 (zh)
BR (1) BR112014018278B1 (zh)
CA (1) CA2862328C (zh)
HK (1) HK1201283A1 (zh)
MX (1) MX360831B (zh)
NZ (1) NZ629378A (zh)
PH (1) PH12014501688A1 (zh)
RU (1) RU2656186C2 (zh)
WO (1) WO2013112995A1 (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2015000789A (es) * 2012-07-19 2015-05-07 Zoetis Llc Composiciones de virus de la gripe bovina.
AR111770A1 (es) 2017-05-05 2019-08-21 Elanco Us Inc Vacuna para enfermedad respiratoria bovina
CN111363855A (zh) * 2020-04-30 2020-07-03 山东省农业科学院家禽研究所（山东省无特定病原鸡研究中心） 一种同时检测a、d型流感病毒的成套试剂、试剂盒及其应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004161781A (ja) * 1992-03-03 2004-06-10 Dai Ichi Seiyaku Co Ltd 経口ワクチン
AUPQ846900A0 (en) * 2000-06-29 2000-07-27 Aruba International Pty Ltd A vaccine
WO2008076371A2 (en) * 2006-12-15 2008-06-26 Schering-Plough Ltd. Method for replicating influenza virus in culture
TW200927928A (en) 2007-09-24 2009-07-01 Nobilon Internat B V Inactivated influenza vaccine
US20090110698A1 (en) * 2007-10-31 2009-04-30 Newport Laboratories, Inc. Method of determining vaccine compliance
RU2428476C1 (ru) * 2010-06-21 2011-09-10 Учреждение Российской Академии Медицинских Наук Научно-исследовательский институт экспериментальной медицины Северо-западного отделения РАМН (НИИЭМ СЗО РАМН) Реассортантный штамм вируса гриппа rn 1/09-swine a(h7n1) для определения антител к нейраминидазе при гриппозной инфекции и вакцинации

Also Published As

Publication number Publication date
RU2656186C2 (ru) 2018-05-31
AU2013211833A1 (en) 2014-09-18
WO2013112995A1 (en) 2013-08-01
CA2862328A1 (en) 2013-08-01
CA2862328C (en) 2021-08-31
NZ629378A (en) 2017-06-30
AU2013211833B2 (en) 2017-09-14
BR112014018278A2 (pt) 2019-04-02
US9278999B2 (en) 2016-03-08
CN104203972A (zh) 2014-12-10
MX360831B (es) 2018-11-16
EP2807184A1 (en) 2014-12-03
JP2015506949A (ja) 2015-03-05
PH12014501688A1 (en) 2014-10-20
JP6257529B2 (ja) 2018-01-10
AU2013211833A2 (en) 2014-09-25
MX2014009022A (es) 2015-03-03
RU2014134850A (ru) 2016-03-20
US20130195915A1 (en) 2013-08-01
BR112014018278B1 (pt) 2023-01-17

Similar Documents

Publication Publication Date Title
IL261204A (en) Influenza virus vaccines and their use
IL262123A (en) Influenza virus vaccines and their uses
HK1199211A1 (zh) 流感病毒疫苗及其用途
HK1214962A1 (zh) 流感病毒免疫原性組合物及其應用
EP2552479A4 (en) INFLUENZA VIRUS VACCINES AND USES THEREOF
HK1223110A1 (zh) 流行性感冒病毒疫苗及其用途
HK1209646A1 (zh) 經鼻流感疫苗組合物
IL240504A0 (en) Combined vaccine for respiratory syncytial virus and influenza
IL229307A0 (en) Inactivated dengue virus vaccine
PT2806891T (pt) Vacinas baseadas no vírus parainfluenza 5
IL240936B (en) Reassortment of influenza virus and methods for their preparation
PL2935313T3 (pl) Szczepionki przeciwko wirusowi zapalenia wątroby typu b
EP2852396A4 (en) INFLUENZA VACCINE CONSTRUCTS
ZA201300395B (en) Influenza vaccine
HK1220656A1 (zh) 減弱的流感病毒和疫苗
IL244354B (en) Flu vaccine and treatment
EP3022298A4 (en) WAXED INFLUENZA VACCINE AND USES THEREOF
HK1201283A1 (zh) 丙型流感病毒和疫苗
SG11201505170WA (en) Dengue virus vaccine composition